Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty
CA 2433041 A1 · Owner: Kogel, Heidi · Inventors: Goppelt, Andreas; Kogel, Heidi; Alzheimer, Christian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of intermediate-conductance calcium-, activated potassium channels and/or the nucleic acids coding for the same from humans or mice, for the diagnosis prevention and/or treatment of , illnesses associated with disturbed keratinocyte activity. The invention also relates to the use of the same for identifying pharmacologically active substances. The invention further relates to the use of modulators of intermediate-conductance, calcium-activated potassium channels for the diagnosis, prevention and/or treatment of illnesses associated with disturbed keratinocyte activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.